The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance
Open accessAbstract
Glucocorticoids (GC) are highly effective in the control of diseases associated with T cell activation. However, a subset of individuals is GC insensitive. Previous studies have demonstrated that IL-2 can induce steroid resistance in mouse T cells. However, the mechanism for this phenomenon is unknown. In the current study we found that the murine cell line (HT-2) is steroid resistant when incubated with IL-2, but steroid sensitive when grown in IL-4. Furthermore, when HT-2 cells are treated with IL-2, the glucocorticoid receptor (GCR) does not translocate to the cell nucleus after dexamethasone treatment. In contrast, the GCR in IL-4-stimulated HT-2 cells does translocate into the cell nucleus after dexamethasone treatment. IL-2-induced steroid insensitivity in HT-2 cells appears to be a signaling event as the effects of IL-2 on nuclear translocation of the GCR occurred within 30 min even in the presence of cycloheximide. Indeed, preincubation of HT-2 cells with a Janus-associated kinase 3 inhibitor restored nuclear translocation of the GCR even in the presence of IL-2. Immunoprecipitation experiments revealed that phosphorylated STAT5 and GCR formed immune complexes. This association may lead to retardation of GCR nuclear translocation because IL-2 was not able to induce steroid insensitivity in splenocytes from STAT5 knockout mice. This study demonstrates a novel role for STAT5 in IL-2-induced steroid insensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“inhibition of prednisolone-induced GR translocation, as well as GR-mediated gene transcription in human epidermal cells by TNF-α, is dependent on ERK activation.46”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JAKS AND STATS: Biological Implications
Leonard, W. J., & O’Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,826
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
Functional interactions between Stat5 and the glucocorticoid receptor
Stöcklin, E., Wissler, M., Gouilleux, F., & Groner, B. (1996) · Nature · doi:10.1038/383726a0 · Cited by 675
Imada, K., & Leonard, W. J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00018-3 · Cited by 610
Gouilleux, F., Wakao, H., Mundt, M., & Groner, B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06756.x · Cited by 588
Kam, J. C., Szefler, S. J., Surs, W., Sher, E., & Leung, D. Y. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3460 · Cited by 449
Self-citationIrusen, E., Matthews, J. G., Takahashi, A., Barnes, P. J., Chung, K. F., & Adcock, I. M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122465 · Cited by 416
Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β
Leung, D. Y. M., Hamid, Q. A., Vottero, A., Szefler, S. J., Surs, W., Minshall, E., Chrousos, G. P., & Klemm, D. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1567 · Cited by 407
Self-citationSher, E., Leung, D. Y. M., Surs, W., Kam, J. C., Zieg, G., Kamada, A. K., & Szefler, S. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116963 · Cited by 394
Self-citationModulation of STAT signaling by STAT-interacting proteins
Shuai, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203522 · Cited by 379
Research works printed but not linked: 37
- 2000, Gastroenterology, 859
- 1990, Respir. Med., 77
- 1990, Am. J. Gastroenterol., 758
- 1986, Lancet, 1296
- 1995, J. Exp. Med., 33
- 2002, J. Allergy Clin. Immunol., 609
- 2000, Am. J. Respir. Crit. Care Med., 1
- 1997, J. Biol. Chem., 26659
- 1994, J. Clin. Invest., 33
- 1993, J. Immunol., 3460
- 1997, J. Biol. Chem., 26665
- 1992, J. Immunol., 107
- 1988, J. Immunol., 1191
- 2001, Blood, 1607
- 2001, J. Biol. Chem., 17815
- 2002, J. Allergy Clin. Immunol., 649
- 2001, J. Exp. Med., 585
- 1997, J. Exp. Med., 1567
- 2002, Am. J. Respir. Cell Mol. Biol., 361
- 2002, J Mol. Med., 309
- 1997, Pulm. Pharmacol. Ther., 3
- 1999, Endocr. Rev., 435
- 2001, J. Endocrinol., 447
- 1998, J. Clin. Immunol., 307
- 2000, Mol. Immunol., 1
- 2000, Oncogene, 2566
- 1998, Annu. Rev. Immunol., 293
- 1994, EMBO J., 4361
- 2000, Oncogene, 2638
- 1999, Mol. Endocrinol., 330
- 1996, Nature, 726
- 2000, FEBS Lett., 229
- 2000, J. Immunol., 5689
- 2001, Mol. Endocrinol., 1062
- 2002, J. Biol. Chem., 26573
- 1999, Mol. Cell. Biol., 1025
- 2001, Mol. Cell. Biol., 3266
Cited by
Sorted by citations
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Kim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Chung, K. F., & Adcock, I. M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00018908 · Cited by 613
The role of T lymphocytes in the pathogenesis of asthma
Larché, M., Robinson, D. S., & Kay, A. B. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.169 · Cited by 574
Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.014 · Cited by 544
Glucocorticosteroids: current and future directions
Barnes, P. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 550
Update on glucocorticoid action and resistance
Nelson, H. S., Leung, D. Y. M., & Bloom, J. W. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.97 · Cited by 415
Self-citationUpdate on glucocorticoid action and resistance
Ito, K., Chung, K. F., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.032 · Cited by 407
Kabata, H., Moro, K., Fukunaga, K., Suzuki, Y., Miyata, J., Masaki, K., Betsuyaku, T., Koyasu, S., & Asano, K. (2013) · Nature Communications · doi:10.1038/ncomms3675 · Cited by 357
Body Mass and Glucocorticoid Response in Asthma
Sutherland, E. R., Goleva, E., Strand, M. J., Beuther, D. A., & Leung, D. Y. M. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-076oc · Cited by 355
Self-citationCytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339
Mechanisms and resistance in glucocorticoid control of inflammation
Barnes, P. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.018 · Cited by 317
Liu, S., Verma, M., Michalec, L., Liu, W., Sripada, A., Rollins, D. R., Good, J. T., Ito, Y., Chu, H., Gorska, M. M., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.03.032 · Cited by 307
Yehuda, R., Cai, G., Golier, J. A., Sarapas, C., Galea, S., Ising, M., Rein, T., Schmeidler, J., Müller-Myhsok, B., Holsboer, F., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.034 · Cited by 294
Increased Glucocorticoid Receptor β Alters Steroid Response in Glucocorticoid-insensitive Asthma
Goleva, E., Li, L., Eves, P. T., Strand, M. J., Martin, R. J., & Leung, D. Y. M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200507-1046oc · Cited by 219
Self-citationMechanisms of Glucocorticoid Receptor Action in Noninflammatory and Inflammatory Cells
Necela, B. M., & Cidlowski, J. A. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200402-005ms · Cited by 220
Matthews, J. G., Ito, K., Barnes, P. J., & Adcock, I. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.018 · Cited by 204
Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks
Sarapas, C., Cai, G., Bierer, L. M., Golier, J. A., Galea, S., Ising, M., Rein, T., Schmeidler, J., Müller-Myhsok, B., Uhr, M., et al. (2011) · Disease Markers · doi:10.1155/2011/328054 · Cited by 143
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease
Iudicibus, S. D. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i9.1095 · Cited by 142
RETRACTED: Kinase inhibitors and airway inflammation
Adcock, I. M., Chung, K. F., Caramori, G., & Ito, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.054 · Cited by 141
RetractedEnhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells
Tsitoura, D. C., & Rothman, P. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18975 · Cited by 133
Li, L.-B., Goleva, E., Hall, C. F., Ou, L.-S., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.005 · Cited by 127
Self-citationJia, Y., Cong, R., Li, R., Yang, X., Sun, Q., Parvizi, N., & Zhao, R. (2012) · Journal of Nutrition · doi:10.3945/jn.112.160341 · Cited by 122
Regulation of Apoptosis by the Ft1 Protein, a New Modulator of Protein Kinase B/Akt
Remy, I., & Michnick, S. W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1493-1504.2004 · Cited by 121
Li, J. J., Wang, W., Baines, K. J., Bowden, N. A., Hansbro, P. M., Gibson, P. G., Kumar, R. K., Foster, P. S., & Yang, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001039 · Cited by 107
Tliba, O., Cidlowski, J. A., & Amrani, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.019679 · Cited by 103
Emerging roles of pulmonary macrophages in driving the development of severe asthma
Yang, M., Kumar, R. K., Hansbro, P. M., & Foster, P. S. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0711357 · Cited by 103
Creed, T., Probert, C. S., Norman, M., Moorghen, M., Shepherd, N. A., Hearing, S. D., Dayan, C. M., & THE BASBUC INVESTIGATORS (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02904.x · Cited by 101
Cytokines Induce an Early Steroid Resistance in Airway Smooth Muscle Cells
Tliba, O., Damera, G., Banerjee, A., Gu, S. Y., Baidouri, H., Keslacy, S., & Amrani, Y. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0226oc · Cited by 90
Stress-Related Immune Markers in Depression: Implications for Treatment
Hughes, M. M., Connor, T. J., & Harkin, A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw001 · Cited by 91
Chiossone, L., Vitale, C., Cottalasso, F., Moretti, S., Azzarone, B. G., Moretta, L., & Mingari, M. C. (2007) · Blood · doi:10.1182/blood-2006-07-037846 · Cited by 81
Su, M., Ouyang, X., & Song, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.038 · Cited by 80
Rotenberg, C., Besnard, V., Brillet, P., Giraudier, S., Nunès, H., & Valeyre, D. (2018) · European Respiratory Journal · doi:10.1183/13993003.01482-2018 · Cited by 84
Sionov, R. V., Spokoini, R., Kfir‐Erenfeld, S., Cohen, O., & Yefenof, E. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00406-5 · Cited by 77
Dominance of the strongest: Inflammatory cytokines versus glucocorticoids
Dejager, L., Vandevyver, S., Πέττα, Ι., & Libert, C. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.006 · Cited by 78
Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy
Hapgood, J. P., Avenant, C., & Moliki, J. M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.002 · Cited by 72
Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue?
Adcock, I. M. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.02.001 · Cited by 71
The Effects of Cytokines on Suppression of Lymphocyte Proliferation by Dexamethasone
Creed, T., Lee, R., Newcomb, P. V., di Mambro, A. J., Raju, M., & Dayan, C. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801998 · Cited by 69
McMaster, A., & Ray, D. W. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.036194 · Cited by 68
The Role of Genes in Defining a Molecular Biology of PTSD
Yehuda, R., Koenen, K. C., Galea, S., & Flory, J. D. (2011) · Disease Markers · doi:10.1155/2011/185354 · Cited by 71
Creed, T., & Probert, C. S. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03156.x · Cited by 66
Mechanisms of glucocorticoid action and insensitivity in airways disease
Boardman, C., Chachi, L., Gavrila, A., Keenan, C. R., Perry, M. M., Xia, Y., Meurs, H., & Sharma, P. K. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.08.008 · Cited by 69
Endoplasmic Reticulum Stress and the Related Signaling Networks in Severe Asthma
Kim, S. R., & Lee, Y. C. (2014) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2015.7.2.106 · Cited by 69
Bhandare, R., Damera, G., Banerjee, A., Flammer, J. R., Keslacy, S., Rogatsky, I., Panettieri, R. A., Amrani, Y., & Tliba, O. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0239rc · Cited by 61
Glucocorticoid-resistant asthma and novel anti-inflammatory drugs
Keenan, C. R., Salem, S., Fietz, E. R., Gualano, R. C., & Stewart, A. G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.011 · Cited by 58
Glucocorticoids and Inflammation: A Double-Headed Sword in Depression?
Horowitz, M. A., Zunszain, P. A., Anacker, C., Musaelyan, K., & Pariante, C. M. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343980 · Cited by 57
Role of Transcription Factors in the Pathogenesis of Asthma and COPD
Caramori, G., Casolari, P., & Adcock, I. M. (2013) · Cell Communication & Adhesion · doi:10.3109/15419061.2013.775257 · Cited by 57
Melatonin Inhibits Glucocorticoid Receptor Nuclear Translocation in Mouse Thymocytes
Presman, D. M., Hoijman, E., Ceballos, N. R., Galigniana, M. D., & Pecci, A. (2006) · Endocrinology · doi:10.1210/en.2006-0252 · Cited by 53
IFN-γ Reverses IL-2– and IL-4–Mediated T-Cell Steroid Resistance
Goleva, E., Li, L., & Leung, D. Y. M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0327oc · Cited by 49
Self-citationInflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis
Byrne, C. J., Khurana, S., Kumar, A., & Tai, T. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00343 · Cited by 52
T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
Kaur, M., Smyth, L. J. C., Cadden, P., Grundy, S., Ray, D. W., Plumb, J., & Singh, D. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-20 · Cited by 42
Hu, F., Pace, T. W. W., & Miller, A. H. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.01.001 · Cited by 42
Regulatory and effector T-cells are differentially modulated by Dexamethasone
Pandolfi, J., Baz, P., Fernández, P. M., Lupi, A. D. D., Payaslián, F., Billordo, L. A., Fainboim, L., & Arruvito, L. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.09.008 · Cited by 38
Rybka, J., Korte, S. M., Czajkowska‐Malinowska, M., Wiese‐Szadkowska, M., Kędziora–Kornatowska, K., & Kędziora, J. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0391-0 · Cited by 37
CD4+CD25int T Cells in Inflammatory Diseases Refractory to Treatment with Glucocorticoids
Lee, R., Creed, T., Schewitz‐Bowers, L. P., Newcomb, P. V., Nicholson, L. B., Dick, A. D., & Dayan, C. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7941 · Cited by 36
Goleva, E., Dunlap, A., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.04.001 · Cited by 33
Self-citationKeenan, C. R., Radojicic, D., Li, M., Radwan, A. M., & Stewart, A. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.006 · Cited by 36
Shannon, A. M., Bouchier‐Hayes, D. J., Condron, C. M., & Toomey, D. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602685 · Cited by 31
STAT signaling as a marker of SLE disease severity and implications for clinical therapy
Goropevšek, A., Holcar, M., Pahor, A., & Avčin, T. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.08.010 · Cited by 29
Meyer, L. K., Delgado-Martín, C., Maude, S. L., Shannon, K., Teachey, D. T., & Hermiston, M. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220026 · Cited by 29
ATF2 impairs glucocorticoid receptor–mediated transactivation in human CD8+ T cells
Li, L., Leung, D. Y. M., Strand, M. J., & Goleva, E. (2007) · Blood · doi:10.1182/blood-2007-01-070755 · Cited by 29
Self-citationDiscovery of GW 870086: a potent anti‐inflammatory steroid with a unique pharmacological profile
Uings, I., Needham, D. A. P., Matthews, J., Haase, M. V., Austin, R., Angell, D. C., Leavens, K., Holt, J., Biggadike, K., & Farrow, S. N. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12232 · Cited by 28
Pace, T. W. W., Hu, F., & Miller, A. H. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.07.227 · Cited by 27
Steroid Refractory CD4 + T Cells in Patients with Sight-Threatening Uveitis
Lee, R., Schewitz‐Bowers, L. P., Nicholson, L. B., Dayan, C. M., & Dick, A. D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3152 · Cited by 27
Mohammed, S., Mahdi, F., & Paris, J. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218212 · Cited by 24
Abdelwahab, S. A., Owada, Y., Kitanaka, N., Adida, A., Sakagami, H., Ono, M., Watanabe, M., Spener, F., & Kondo, H. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9050-1 · Cited by 23
ILC2 Diversity, Location, and Function in Pulmonary Disease
Verma, M., Can, U. I., & Reinhardt, R. L. (2025) · Immunological Reviews · doi:10.1111/imr.70036 · Cited by 22
Musselman, D. L., Royster, E. B., Wang, M., Long, Q., Trimble, L. M., Mann, T. K., Graciaa, D. S., McNutt, M. D., Auyeung, N. S. F., Oliver, L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.85 · Cited by 23
IL‐2 modulates Th2 cell responses to glucocorticosteroid: A cause of persistent type 2 inflammation?
Kanagalingam, T., Solomon, L. A., Vijeyakumaran, M., Palikhe, N. S., Vliagoftis, H., & Cameron, L. (2019) · Immunity Inflammation and Disease · doi:10.1002/iid3.249 · Cited by 22
Lührmann, A., Tschernig, T., von der Leyen, H. E., Hecker, M., Pabst, R., & Wagner, A. H. (2010) · Experimental Lung Research · doi:10.3109/01902140903144138 · Cited by 22
Psychoneuroimmunology of Depressive Disorder: Mechanisms and Clinical Implications
Capuron, L., Miller, A. H., & Irwin, M. R. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50030-7 · Cited by 22
Glucocorticoid Resistance in Inflammatory Diseases
Chrousos, G., & Franchimont, D. (2004) · CRC Press eBooks · doi:10.1201/9780203021941-39 · Cited by 21
Besnard, V., & Jeny, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082445 · Cited by 19
Pharmacogenomics in the Treatment of Inflammatory Bowel Disease
Smith, M. A., Marinaki, A. M., & Sanderson, J. D. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.4 · Cited by 16
Therapeutic targets for new therapy for corticosteroid refractory asthma
Ito, K., & Mercado, N. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903078431 · Cited by 15
Singh, J., Kumari, S., Arora, M., Verma, D., Palanichamy, J. K., Kumar, R., Sharma, G., Bakhshi, S., Pushpam, D., Ali, M. S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.606370 · Cited by 14
Yehuda, R., Cai, G., Golier, J. A., Sarapas, C., Galea, S., & ISING, M. (2009) · PsycEXTRA Dataset · doi:10.1037/e717702011-009 · Cited by 15
Mahajan, R., Singh, A., Kedia, S., Kaur, K., Midha, V., Sahu, P., Mehta, V., Singh, D., Bansal, N., Dharni, K., et al. (2021) · Intestinal Research · doi:10.5217/ir.2020.00100 · Cited by 13
Glucocorticoids and the emerging importance of T cell subsets in steroid refractory diseases
Schewitz‐Bowers, L. P., Lee, R., Dayan, C. M., & Dick, A. D. (2008) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802334848 · Cited by 11
Research progress of glucocorticoid resistance in chronic rhinosinusitis with nasal polyps: A review
Chen, L., Fan, X., Li-na, Y., Han, L., Wang, N., & Bian, K. (2023) · Medicine · doi:10.1097/md.0000000000036024 · Cited by 10
T cells from burn-injured mice demonstrate a loss of sensitivity to glucocorticoids
D’Elia, M., Patenaude, J., Dupras, C., & Bernier, J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00084.2010 · Cited by 10
CD56+ Cells Induce Steroid Resistance in B Cells Exposed to IL-15
Xu, Q., Goleva, E., Ou, L.-S., Li, L.-B., & Leung, D. Y. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7110 · Cited by 9
Self-citationPharmacokinetic and pharmacodynamic properties important for inhaled corticosteroids
Hochhaus, G. (2007) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60703-x · Cited by 9
Mohammed, S., Qrareya, A. N., Mahdi, F., Moss, E. M., Akins, N. S., Li, J., Le, H. V., & Paris, J. J. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13047 · Cited by 9
Gutsol, A. A., Сохоневич, Н. А., Yurova, K. A., Геннадьевна, Х. О., Shupletsova, V. V., & Litvinova, L. S. (2015) · Molecular Biology · doi:10.1134/s0026893314060065 · Cited by 8
Mitogen-activated protein kinase pathways: Therapeutic targets in steroid resistance?
Bloom, J. W. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.09.001 · Cited by 8
McGuinness, B. W., & Harkin, A. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_3 · Cited by 7
Liu, H., Liu, X., Zhang, G., Wang, J., Naren, D., Xie, S., Li, Y., Nie, D., Li, Z., & Ma, L. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.08.014 · Cited by 4
Navigating glucocorticoid resistance: From GR isoforms to nuclear condensates
Wang, C., Zhong, Y., Tang, M., He, X., Xu, S., & Zhang, J. (2025) · Cell investigation. · doi:10.1016/j.clnves.2025.100059 · Cited by 3
Steroid Sensitivity in Uveitis
Lee, R., Schewitz‐Bowers, L. P., Raveney, B. J. E., & Dick, A. D. (2008) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-540-69459-5_5 · Cited by 3
A role for STAT5 in steroid-resistant UC?
Löwenberg, M., Scheffer, M., Verhaar, A. P., Peppelenbosch, M. P., & Hommes, D. W. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000225331.76237.28 · Cited by 3
Genetic Markers for PTSD Risk and Resilience Among Survivors of the World Trade Center Attacks
Yehuda, R. (2012) · PsycEXTRA Dataset · doi:10.1037/e533652013-116 · Cited by 2
Thymic Stromal Lymphopoietin May Induce Steroid Resistance in Minimal Change Disease
Nakayama, M., Suzuki, H., Fukao, Y., Nihei, Y., & Suzuki, Y. (2025) · Nephrology · doi:10.1111/nep.70123 · Cited by 1
The timing of antenatal glucocorticoids determines the receptor sensitivity in preterm infants
Fortmann, I., Britsemmer, J. H., Lehmann, M., Taege, N., Oster, H., Kirchner, H., Haertel, C., & Astiz, M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag066 · Cited by 1
Genetics and Genomics of Posttraumatic Stress Disorder
Uddin, M., Amstadter, A. B., Nugent, N. R., & Koenen, K. C. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195399066.013.0011 · Cited by 1
Sahib, A. A., & A.Al-Shaikely, A. W. (2017) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol17iss1pp47-54 · Cited by 1
Nekoeian, S., Ferdowsian, S., Asgari, Y., & Azizi, Z. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00707-0 · Cited by 1
Harvey, I. C., Richard, A. J., Mendoza, T. M., & Stephens, J. M. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00116.2023 · Cited by 1
Kim, S. R. (2017) · Springer eBooks · doi:10.1007/978-981-10-1998-2_3 · Cited by 1
Metadata
- Authors
- Goleva, E., Kisich, K. O., & Leung, D. Y. M.
- Affiliations
- National Jewish Health (US)
- Corresponding author
- Goleva, Elena
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-11
- Volume
- 169
- Issue
- 10
- Pages
- 5934-5940
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2171016604
- Cited by
- 113
- References
- 37
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 8 · 2014: 3 · 2013: 7 · 2012: 5
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HL37260, RR00051)
- National Heart, Lung, and Blood Institute (HL 36577, P01HL036577, HL 37260)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 41256, R01AR041256)
- National Center for Research Resources (RR-00051)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- STAT5, glucocorticoid resistance, interleukin-2, glucocorticoid receptor, nuclear translocation, dexamethasone, IL-4, T cell activation, immune complex formation
- MeSH terms
- Animals, Cell Division, Cell Line, Cell Nucleus, Cells, Cultured, Dexamethasone, DNA-Binding Proteins, Drug Resistance, Enzyme Inhibitors, Interleukin-2, Mice, Inbred C57BL, Milk Proteins, Protein-Tyrosine Kinases, Receptors, Glucocorticoid, Spleen, T-Lymphocytes, Signal Transduction, Trans-Activators, Mice, Knockout, Dimerization, Active Transport, Cell Nucleus, STAT5 Transcription Factor, Mice, Janus Kinase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review